Varma Mutual Pension Insurance Co Purchases New Holdings in Danaher Corporation $DHR

Varma Mutual Pension Insurance Co acquired a new position in Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel reports. The firm acquired 27,820 shares of the conglomerate’s stock, valued at approximately $20,032,000.

Several other large investors also recently added to or reduced their stakes in DHR. Sivia Capital Partners LLC boosted its position in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the period. First Trust Advisors LP grew its holdings in shares of Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC raised its position in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC lifted its stake in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after acquiring an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC lifted its stake in Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after acquiring an additional 325 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of DHR opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The firm’s 50 day moving average price is $195.80 and its 200 day moving average price is $192.61. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the firm posted $0.77 earnings per share. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have weighed in on DHR shares. Stifel Nicolaus lowered their target price on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Piper Sandler assumed coverage on shares of Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective on the stock. Finally, DZ Bank began coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.